HUTCHMED's stock price soared 5.03% during intraday trading on Friday, following the release of the company's exceptional annual financial results.
The pharmaceutical company announced annual results showing a profit attributable to shareholders of $457 million, representing a massive 1111.03% increase compared to the previous year. This dramatic improvement in profitability appears to be the primary driver behind the stock's significant price movement.